88
methylmalonic acid assay.
Blood 1993, 82 (10 Suppl 1): 1850.
4. Norman, Eric. Vitamin B
12
deficiency.
Journal of Family Practice1993, 36:597.
5. Walker III, Sydney.
Dose of Sanity. New York: John Wiley&Sons
1996, p. 192.
6. Lopponen, M., Raiha, I., Isoaho, R., Vahlberg, T, Kivela, S.L.
Diagnosing cognitive impairment and dementia in primary health care — a more active approach is needed.
Age and Ageing 32 (6): 606–12.
7. Интервю с Mark Goodman в
Clinical Pearls News 1997,
7(10):132-134.
8. Teunisse, S., Bollen, A.E., Van Gool, W.A., Walstra, G.J.M.
Dementia and subnormal levels of vitamin B
12
: effects of replacement therapy on dementia.
Journal of Neurology 1996, 243 (7):522-529.
9. Bernstein, Leslie. Vital signs: Dementia without a cause.
DiscoverFeb. 2000, 21(2):31-2.
10. Цит. в: Hector,
Melvin and Burton, John. What are the psychiatric manifestations of vitamin BI2 deficiency?
Journal of theAmerican Geriatric Society 1988, 36:1105-1112.
11. Reid, S.D. Pseudodementia in a twenty-one-year-old with bipolar disorder and vitamin B
12
and folate deficiency.
West Indian MedicalJournal 2000, 49(4):347-8.
12. Clarke, R., Smith, A.D., Jobst, K.A., Refsum, H., Sutton, L.,
Ueland, P.M. Folate, vitamin B
12
and serum total homocysteine levels in confirmed Alzheimer’s disease.
Archives of Neurology 1998, 55:1449-55.
13. McCaddon, A., Kelly, C.L. Familial Alzheimer’s
disease and vitamin B12
deficiency.
Age and Ageing 1994, 23(4):334-7.
14. Wang, H.X., Wahlin. A., Basun, H.Fastbom, J., Wmblad, B.,
Fratiglioni, L. Vitamin B
12
and folate in relation to the development of
Alzhaimer’s disease.
Neurology 2001, 56:1188-94.
15. Meins, W., Muller-Thomsen, T., Meier-Baumgartnerm, H.P.
Subnormal serum vitamin B
12
and behavioral and psychological symptoms in Alzheimer’s disease.
International Journal of Geriatric Psychiatry 2000,
15(5):415-8.
16. Vogyatzoglou, A. et al. Vitamin B
12
status and rate of brain volume loss in community-dwelling elderly.
Neurology 2008, 71:826-832.
89 17. Isajiw, G.
To peg or not to peg: A case of a hospice referral forvitamin B12 deficiency. The Linacre Quarterly 76(2), May 2009:212-217.
18. Smith. A. D., Refsum. H. Vitamin B
12
and cognition in the elderly.
Am J Clin Nutr 2009; 89(suppl):707S-11S.
19. Mitra, K., Gangopadhaya, P.K., Das, S.K. Parkinsonism plus syndrome —
A review Neurol India 2003, 51:183-8.
20. Статистиката е взета от: „Falls and hip fractures among older adults“ Centers for Disease Control and Prevention, Nov. 2000,
http://www.cdc.gov
21. Karantanas, A.H., Markonis, A., Bisbiyiannis, G.
Subacutecombined degeneration of the spinal cord with involvement of the anteriorcolumns: A new MRI finging. Neuroradiology 2000, 42:115-117.
22. Stone, K. L., Bauer, D.C., Sellmeyer, D., Cummings, S.R.
Low serum vitamin B12
levels are associated with increased hip bone loss in older women:
A prospective study.
Journal of ClinicalEndocrinology&Metabolism 2004, 89(3):1217-21.
23. McLean, R.R. et al. homocysteine as a predictive factor for hip fracture in older persons.
New England Journal of Medicine 2004,
350:2042-2049.
24. Van Meurs, J.B.J., et al. Homocysteine levels and the risk of osteoporotic fracture.
New England Journal of Medicine 2004, 350:2033-
41.
25. Goerss, J.B. et al. Risk of fractures in patients with pernicious anemia.
J Bone Miner Res May 1992, 7(5):573-9. Espallargues, M., et al.
Identifying bone-mass related risk factors for fracture to guide bone densitometry measurements: A systematic review of the literature.
Osteoporosis Int. 2001, 12(10):811-22.
26. Mellton, M.E., Kochman, M L. Reversal of severe osteoporosis with vitamin B
12
and etidronate therapy in a patient with pernicious anemia.
Gastroenterology, Apr. 2010, 138(4):1330-7.
28. Kuzniarz, M., Mitchell, P.F., Gumming, R.G., Flood, V.M. Use of vitamin supplements and cataract: The Blue Mountains Eye Study.
American Journal of Ophthalmology 2001, 132:19-26.
[1]
Дефицитът на B
12
може да предизвика сериозна анемия,
налагаща кръвопреливане. Лекарите обикновено отъждествяват
90
тежката анемия с вътрешни кръвоизливи и не назначават изследвания за B
12
и желязо преди трансфузията. Изследването на тези показатели впоследствие дава неточни резултати, замъгляващи клиничната картина.
↑
[2]
Цената на изследването на ММК в урина в Norman Clinical
Laboratory, Inc. е 150 долара; в Mayo Clinic u Specialty Laboratory —
249 долара. — Бел.авт.
↑
[3]
В България тези цени са многократно по-ниски. Към 2015 г.
стойността на
изследването за B12
в повечето лаборатории е в диапазона 15–20 лв., а за хомоцистеин — 25–30 лв. — Бел.прев.
↑
[4]
За съжаление, тези учени не са включили в изследването си серумен B
12
в сивата зона, нито ММК в урина. Основният въпрос, към който трябва да се насочат бъдещите изследвания, е колко пациенти с потвърдена болест на Алцхаймер имат нелекуван дефицит на B
12
,
демонстриран
със серумен B12
в сивата зона или повишена ММК в урината. — Бел.авт.
↑